Schedule 13G ownership disclosure

ENVVENO MEDICAL CORPORATION

Common Stock, $0.00001 par value · CUSIP: 29415J106

Event date: 2025-09-02

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Kingdon Capital Management, L.L.C.

    Shares: 1,359,261.00 · Class: 7.1%

  • M. Kingdon Offshore Master Fund, L.P.

    Shares: 1,265,845.00 · Class: 6.6%

  • Kingdon GP, LLC

    Shares: 1,265,845.00 · Class: 6.6%

  • Mark Kingdon

    Shares: 1,359,261.00 · Class: 7.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000919574-25-005609
Form type
SCHEDULE 13G
Filer
KINGDON CAPITAL MANAGEMENT, L.L.C.
CIK
CIK 1000097
Filed
Sep 09, 2025
Reporting period
Sep 02, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub